Laura Marroqui

Elche, VC 03202, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

A microbiota-informed pipeline for in vitro characterisation of insulinotropic properties of dairy fermentates using static EndoC-βH1 and dynamic microfluidic models.

A microbiota-informed pipeline for in vitro characterisation of insulinotropic properties of dairy fermentates using static EndoC-βH1 and dynamic microfluidic models.

Journal: Food research international (Ottawa, Ont.)

Published: May 13, 2026

Inhibition of glucagon secretion from pancreatic α-cells by the bile acid TUDCA involves a S1PR2-PI3K pathway.

Inhibition of glucagon secretion from pancreatic α-cells by the bile acid TUDCA involves a S1PR2-PI3K pathway.

Journal: The Journal of nutritional biochemistry

Published: May 29, 2025

GPR41 and GPR43 modulate rodent pancreatic α-cell function and growth.

GPR41 and GPR43 modulate rodent pancreatic α-cell function and growth.

Journal: Life sciences

Published: May 27, 2025

Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function.

Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function.

Journal: Biomedicines

Published: December 13, 2024

Gut microbial metabolic signatures in diabetes mellitus and potential preventive and therapeutic applications.

Gut microbial metabolic signatures in diabetes mellitus and potential preventive and therapeutic applications.

Journal: Gut microbes

Published: October 18, 2024

Hyperglucagonemia and glucagon hypersecretion in early type 2 diabetes result from multifaceted dysregulation of pancreatic mouse α-cells.

Hyperglucagonemia and glucagon hypersecretion in early type 2 diabetes result from multifaceted dysregulation of pancreatic mouse α-cells.

Journal: Pflugers Archiv : European journal of physiology

Published: June 18, 2024

Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults.

Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults.

Journal: Frontiers in immunology

Published: July 20, 2023

SUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes.

SUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes.

Journal: The Journal of clinical investigation

Published: June 21, 2023

BCL-XL Overexpression Protects Pancreatic β-Cells against Cytokine- and Palmitate-Induced Apoptosis.

BCL-XL Overexpression Protects Pancreatic β-Cells against Cytokine- and Palmitate-Induced Apoptosis.

Journal: International journal of molecular sciences

Published: January 23, 2023

Screening of Metabolism-Disrupting Chemicals on Pancreatic α-Cells Using In Vitro Methods.

Screening of Metabolism-Disrupting Chemicals on Pancreatic α-Cells Using In Vitro Methods.

Journal: International journal of molecular sciences

Published: November 15, 2022

In Vitro Assays to Identify Metabolism-Disrupting Chemicals with Diabetogenic Activity in a Human Pancreatic β-Cell Model.

In Vitro Assays to Identify Metabolism-Disrupting Chemicals with Diabetogenic Activity in a Human Pancreatic β-Cell Model.

Journal: International journal of molecular sciences

Published: March 25, 2022

G protein-coupled estrogen receptor activation by bisphenol-A disrupts the protection from apoptosis conferred by the estrogen receptors ERα and ERβ in pancreatic beta cells.

G protein-coupled estrogen receptor activation by bisphenol-A disrupts the protection from apoptosis conferred by the estrogen receptors ERα and ERβ in pancreatic beta cells.

Journal: Environment international

Published: February 11, 2022

Showing 1-12 of 44

Last Updated: 09/26/2026